BIBN 4096BS
| Title | Journal |
|---|---|
| A second trigeminal CGRP receptor: function and expression of the AMY1 receptor. | Annals of clinical and translational neurology 20150601 |
| Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists. | Bioorganic & medicinal chemistry letters 20140201 |
| CGRP receptor antagonism and migraine therapy. | Current protein & peptide science 20130801 |
| Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat. | Pain 20120901 |
| CGRP receptor antagonists: an expanding drug class for acute migraine? | Expert opinion on investigational drugs 20120601 |
| Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. | Pain 20110701 |
| Possible site of action of CGRP antagonists in migraine. | Cephalalgia : an international journal of headache 20110401 |
| Evidence for CGRP re-uptake in rat dura mater encephali. | British journal of pharmacology 20101201 |
| [Calcitonin gene-related peptide and migraine. Increases understanding of physiopathology can lead to new drug therapy]. | Lakartidningen 20101201 |
| CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine. | Cephalalgia : an international journal of headache 20101101 |
| Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. | Brain : a journal of neurology 20100901 |
| Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine. | CNS drugs 20100701 |
| Calcitonin gene-related peptide receptor antagonists for migraine. | Expert opinion on investigational drugs 20100701 |
| New acute treatments for headache. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20100601 |
| CGRP receptor antagonism and migraine. | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20100401 |
| Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding. | Biochemical and biophysical research communications 20100326 |
| Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine. | Cephalalgia : an international journal of headache 20100101 |
| Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment. | The journal of headache and pain 20091201 |
| The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. | Pharmacology & therapeutics 20091201 |
| Is there an inherent limit to acute migraine treatment efficacy? | The journal of headache and pain 20091201 |
| Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review. | Expert opinion on therapeutic patents 20091201 |
| CGRP antagonists: hope for a new era in acute migraine treatment. | Acta neurologica Belgica 20091201 |
| Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. | Brain : a journal of neurology 20091101 |
| [Migraine can signal a risk for heart and brain]. | MMW Fortschritte der Medizin 20090910 |
| A flexible and high throughput liquid chromatography-tandem mass spectrometric assay for the quantitation of telcagepant in human plasma. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090515 |
| Migraine and telcagepant [corrected]. | Lancet (London, England) 20090321 |
| CGRP receptors in the control of pain and inflammation. | Current opinion in pharmacology 20090201 |
| Proinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic class. | Expert review of neurotherapeutics 20080901 |
| Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine. | Headache 20080901 |
| Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. | The journal of headache and pain 20080201 |
| Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment. | IDrugs : the investigational drugs journal 20070801 |
| Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries. | Naunyn-Schmiedeberg's archives of pharmacology 20070301 |
| Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1. | Molecular pharmacology 20061201 |
| Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery. | Naunyn-Schmiedeberg's archives of pharmacology 20061201 |
| Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead. | Bioorganic & medicinal chemistry letters 20060515 |
| Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine. | Journal of medicinal chemistry 20050922 |
| CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS. | British journal of pharmacology 20031001 |
| Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. | British journal of pharmacology 20030901 |
| Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. | The Journal of biological chemistry 20020419 |
| Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. | British journal of pharmacology 20000201 |